Restless Leg Syndrome (RLS)
11
6
6
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (11)
Validating the Use of a Subjectively Reported Sleep Vital Sign
The Effect of Spinal Cord Stimulators on Restless Leg Syndrome
Stellate Ganglion Stimulation for Restless Leg Syndrome in Hemodialysis Patients
Study on the Efficacy of Spinal Cord Stimulation in Patients With Severe Refractory Primary or Secondary RLS
Using Cannabis to Treat Restless Legs Syndrome
Novel Calcium Channel Modulators in RLS and Variants: Efficacy & Safety
Combined Effects of Near-Infrared Light and Vibration on Diabetic Patients With Restless Leg Syndrome
Effect of Autogenic Training on Hemodialysis Patients
Peroneal Electrical Nerve Stimulation in Pregnancy for Restless Legs Syndrome
Observe Change in Nasal Swab DRD2 Gene Expression in Restless Legs Syndrome (RLS) Patients on Prolonged Dopamine Agonist Treatment
Effects of PNF Stretching vs Conventional Physical Therapy on the Symptoms of Restless Leg Syndrome in Elderly Population.